Seconds before William Lopez was set to be connected to a dialysis machine at a state-run clinic in the western Venezuelan city of Maracaibo in April, the power went out.
Pfizer Inc's new atopic dermatitis treatment met the main goals in a late-stage study that tested the drug in patients aged 12 and older with moderate to severe forms of the disease, the drugmaker said on Wednesday.
A recent clash with the National Rifle Association (NRA) has shown some doctors who treat gunshot victims a way to heal their own trauma: through activism against gun violence.
Alabama's state Senate passed a bill on Tuesday to outlaw nearly all abortions, creating exceptions only to protect the mother's health, as part of a multistate effort to have the U.S. Supreme Court reconsider a woman's constitutional right to an abortion.
A Japanese government panel approved on Wednesday a price of 33.5 million yen ($305,800) for Novartis' cancer treatment Kymriah, allowing the Swiss drugmaker to press ahead with a campaign to kick-start sluggish sales of the treatment.
Novartis scored a win in litigation over one of the patents underlying its cancer treatment Afinitor, as a federal appeals court on Monday rejected arguments by the would-be maker of a generic version that the patent is invalid.
England's National Health Service said it had reached a deal to pay for U.S. drugmaker Biogen Inc's expensive spinal muscle atrophy treatment Spinraza.
Independent experts on an advisory panel to the U.S. Food and Drug Administration on Tuesday voted against Daiichi Sankyo Co Ltd's treatment for adults with a type of acute myeloid leukemia.
(Reuters Health) - While the number of Americans getting drug treatment for opioid addiction is on the rise, a new study suggests that gains may be concentrated among white patients and people who can pay cash or have private health insurance.
(Reuters Health) - People having surgery may be more likely to experience cardiovascular problems afterward when they have a common nighttime breathing disorder known as sleep apnea, a study suggests.
Bayer shares fell by as much as 5 percent on Tuesday after a California couple were awarded more than $2 billion in the largest U.S. jury penalty over allegations its Roundup weed killer causes cancer.
